The FXR agonist obeticholic acid (OCA) can normalize insulin sensitivity in visceral preadipocytes as well as improve liver function and adipose tissue function in rabbits with metabolic syndrome (43). The gene discussed is NR1H4; the disease is metabolic syndrome.